NeoStem, PreSERVE study, AMI, ACC.15, NBS10, CD34 stem cells

NeoStem Inc. presented updated efficacy and safety results from the one-year follow-up for its Phase 2 PreSERVE study and additional analyses of certain functional tests at the American College of Cardiologyñ€ℱs 64th annual scientific session and expo in March. The one-year follow-up results are defined as all data accumulated until the last patient enrolled completed 12-month follow-up. Thus, the results actually represent data from patients with a median follow-up of 18 months.

Medtronic plc announced the first in-office implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study. One of the world's smallest cardiac monitors, the Reveal LINQ insertable cardiac monitor (ICM) was successfully implanted in an office setting at Scripps Clinic in La Jolla, California, by cardiologist John Rogers, M.D. The RIO 2 study will determine if the procedure, performed in an in-office setting, is as safe as procedures performed in a traditional hospital setting — such as an operating room, cardiac catheterization laboratory or electrophysiology laboratory.

Medtronic plc announced that its Protege GPS self-expanding peripheral stent system has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of stenotic lesions of the common and external iliac arteries.

Vital Images Inc. will debut its U.S. Food and Drug Administration (FDA) 510(k)-cleared CT Myocardial Perfusion application at the 10th annual scientific meeting of the Society of Cardiovascular Computed Tomography (SCCT). The meeting will be held in Las Vegas July 16-19.

Infinitt announced today that it has entered into a seven-year Partner Plus Agreement with TridentUSA Health Services based on an unlimited software licensing model for Infinitt PACS and Cardiology Suite, in addition to custom software development. The contract also encompasses Infinitt's embedded voice recognition and reporting software, as well as the new Gx Communicator package (Critical Results, Peer Review and Collaborator Instant Messaging).

Konica Minolta Medical Imaging announced new Blue Moon Lifecycle Solutions designed to help customers minimize downtime, maximize productivity, and eliminate risk for the lifetime of their handheld Sonimage P3 and portable Sonimage HS1 ultrasound systems. The company will introduce the new Blue Moon Lifecycle Solutions at the Association for Medical Imaging Management (AHRA) annual meeting, July 20-22 in Las Vegas.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now